Company / Net Debt per Share
BeOne Medicines Ltd. Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$2.67
FY2025
5-year range
-$3.46 / -$1.81
FY2021-FY2025
Trend
-47.8%
vs FY2024
Sector context
#71 of 82
Health Care
What the data says
BeOne Medicines Ltd.'s net debt per share of $-2.67 is lower than 87% of companies in the Health Care sector (FY2025). Net Debt per Share has fluctuated over the past 10 years, ranging from $-3.46 in FY2021 to $-0.45 in FY2017.
Based on SEC 10-K filings.
-2.67 in FY2025.
Improved from $-2.19 to $-2.67 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 82This company -$2.67 Sector average $1.13
▼
-336.7% below sector average
Key checks
Key Insights
- In FY2025, net debt per share decreased 47.8% year-over-year.
- Ranks #71 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2017.
- Lowest net debt per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.82 (distress zone, below 1.8 threshold)
- Negative profit margin: -16.9%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$2.67 | -47.8% |
| FY2024 | -$1.81 | +17.5% |
| FY2023 | -$2.19 | +20.0% |
| FY2022 | -$2.74 | +20.7% |
| FY2021 | -$3.46 | -131.4% |
| FY2020 | -$1.50 | -117.1% |
| FY2019 | -$0.69 | +39.3% |
| FY2018 | -$1.14 | -154.2% |
| FY2017 | -$0.45 | +26.1% |
| FY2016 | -$0.60 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026